ROLE OF ANTI-MULLERIAN HORMONE IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME ON METFORMIN THERAPY.
Dr. Roya Rozati, Dr. Surayya Tahseen*, Dr. Akhila Reddy, Dr. Nazima Allaudin, Dr. FatimaTahniyath, Dr. Fatima Hafeez4 and Ayyapathi Mehdi Gautam
ABSTRACT
Background: AMH production by granulosa cells in the polycystic ovary is 2-3 fold increase compared to healthy
women. Purpose of the study: Anti-Mullerian hormone (AMH) is produced by the granulosa cells surrounding
prenatal and antral follicles and has an important role in the development and maturation of follicles. Several
studies have suggested that AMH serum levels may be a marker for polycystic ovary syndrome (PCOS).
Methods: Prospective study was conducted in the Department of Obstetrics and Gynaecology, Owaisi Hospital
and Research Centre and Princess Esra Hospital, Deccan College of Medical Sciences, Hyderabad from March
2014- April 2015. Results: A total of 34 patients diagnosed cases of PCOS. Mean serum Anti Mullerian hormone
levels were significantly decreased in PCOS population on metformin therapy as compared to PCOS population
not on metformin therapy. Conclusion : Serum AMH is a useful prognostic biochemical marker for metformin
therapy in PCOS .
Keywords: granulosa, Anti-Mullerian, antral follicles.
[Full Text Article]
[Download Certificate]